Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab.
Saved in:
| Title: | Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab. |
|---|---|
| Authors: | Coates LC; University of Oxford, Oxford, UK., Abraham S; National Institute for Health Research/Wellcome CRF, Imperial College Healthcare NHS Trust, London, UK., Tillett W; Royal National Hospital for Rheumatic Diseases, Pharmacy and Pharmacology, University of Bath, Bath, UK., Mease PJ; Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle., Ramiro S; Leiden University Medical Center, Leiden, and Zuyderland Medical Center, Heerlen, The Netherlands., Wu T; AbbVie, North Chicago, Illinois., Wang X; AbbVie, North Chicago, Illinois., Pangan AL; AbbVie, North Chicago, Illinois., Song IH; AbbVie, North Chicago, Illinois. |
| Source: | Arthritis care & research [Arthritis Care Res (Hoboken)] 2022 Feb; Vol. 74 (2), pp. 259-267. Date of Electronic Publication: 2021 Dec 29. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Validation Study |
| Journal Info: | Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2151-4658 (Electronic) Linking ISSN: 2151464X NLM ISO Abbreviation: Arthritis Care Res (Hoboken) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
